. 2017 Feb 7;17:55. doi: 10.1186/s12888-017-1229-y

Table 1.

Study measures and measurement points

	MINI^a	PHQ-9^b	NDDIE^c	GAD-7^d	DASS-21^e	WSAS^f	Subjective usefulness of the program	INEP^g	Epilepsy symptom severity^h	Medication adherenceⁱ	Health-related quality of life^j	ESMS^k
T0 baseline	X	X	X	X	X	X			X	X	X	X
T1 (3 months post-baseline)		X	X	X	X	X	X^l	X^l	X	X	X	X
T2 (6 months post-baseline)		X	X	X	X	X	X	X^m	X	X	X
T3 (9 months post-baseline)		X	X	X	X	X	X^m		X	X	X

^aMINI Neuropsychiatric Interview

^bPatient Health Questionnaire

^cNeurological Disorders Depression Inventory for Epilepsy

^dGeneralized Anxiety Disorder questionnaire, 7 items

^eDepression and Anxiety Scales

^fWork and Social Adjustment Scale

^gInventory for the Assessment of Negative Effects of Psychotherapy

^hPESOS and Liverpool Seizure Severity Scale (LSSS)

ⁱRief Adherence Index (RAI)

^jQOLIE-10-P (Quality of Life Inventory in Epilepsy)

^kEpilepsy Self-Management Scale

^lOnly patients in the intervention group

^mOnly patients in the control group